Evidence map›Paper›PMID 31315614›Full record

ArticleMalaria journal2019

Diagnostic dose determination and efficacy of chlorfenapyr and clothianidin insecticides against Anopheles malaria vector populations of western Kenya.

Silas Agumba, John E Gimnig, Lilian Ogonda, Maurice Ombok, Jackline Kosgei, Stephen Munga, Benard Guyah, Seline Omondi, Eric Ochomo

Open access · goldAbstract read
In one paragraph

Article in Malaria journal, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
5.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 67 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Efficacy of PermaNetMalaria journal · 2024
    Article
  7. Field-evolved resistance to neonicotinoids in the mosquito,bioRxiv : the preprint server for biology · 2024
    Article
  8. Functional Validation of Endogenous Redox PartnerInternational journal of molecular sciences · 2024
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Silas AgumbaMaseno University, Private Bag, Maseno, Kenya. s_agumba@yahoo.com.
John E GimnigDivision of Parasitic Diseases and Malaria, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, GA, 30333, USA.
Lilian OgondaMaseno University, Private Bag, Maseno, Kenya.
Maurice OmbokCentre for Global Health Research, Kenya Medical Research Institute, PO Box 1578-40100, Kisumu, Kenya.
Jackline KosgeiCentre for Global Health Research, Kenya Medical Research Institute, PO Box 1578-40100, Kisumu, Kenya.
Stephen MungaCentre for Global Health Research, Kenya Medical Research Institute, PO Box 1578-40100, Kisumu, Kenya.
Benard GuyahMaseno University, Private Bag, Maseno, Kenya.
Seline OmondiCentre for Global Health Research, Kenya Medical Research Institute, PO Box 1578-40100, Kisumu, Kenya.
Eric OchomoCentre for Global Health Research, Kenya Medical Research Institute, PO Box 1578-40100, Kisumu, Kenya.
Kenya Medical Research Institute · KEMaseno University · KECenter for Global Health · US

Funding

National Commission for Science, Technology and Innovation NRF 1st call of abstract FY 2016/2017
6 · The paper itself

Abstract

backgroundMalaria vector control is dependent on chemical insecticides applied to walls by indoor residual spraying or on long-lasting insecticidal nets. The emergence and spread of insecticide resistance in major malaria vectors may compromise malaria control and elimination efforts. The aim of this study was to estimate a diagnostic dose for chlorfenapyr (class: pyrrole) and clothianidin (class: neonicotinoid) and assess the baseline susceptibility of three major Anopheles malaria vectors of western Kenya to these two insecticides.

methodsThe Centers for Disease Control and Prevention (CDC) bottle assay was used to determine the diagnostic doses of chlorfenapyr and clothianidin insecticides against the susceptible Kisumu strain of Anopheles gambiae. Probit analysis was used to determine the lethal doses at which 50% (LD50) and 99% (LD99) of the susceptible mosquitoes would be killed 24, 48 and 72 h following exposure for 1 h. Insecticidal efficacy of chlorfenapyr, clothianidin and the pyrethroid deltamethrin was then evaluated against field collected female Anopheles mosquitoes sampled from Nyando, Bumula and Ndhiwa sub-Counties in western Kenya. Members of Anopheles funestus and An. gambiae complexes were identified using polymerase chain reaction (PCR).

resultsThe determined diagnostic doses of chlorfenapyr and clothianidin insecticides were 50 µg/bottle and 150 µg/bottle, respectively, for An. gambiae, Kisumu strain. When exposed to the diagnostic dose of each insecticide, Anopheles malaria vector populations in western Kenya were susceptible to both insecticides with 100% mortality observed after 72 h. Mortality of mosquitoes exposed to deltamethrin increased over time but did not reach 100%. Mortality of Anopheles arabiensis from Nyando exposed to deltamethrin was 83% at 24 h, 88% at 48 h and 94.5% at 72 h while An. funestus from Ndhiwa was 89% at 24 h, 91.5% at 48 h and 94.5% at 72 h.

conclusionMosquitoes of western Kenya, despite being resistant to pyrethroids, are susceptible to chlorfenapyr and clothianidin. Field evaluations of the formulated product are needed.

Indexed as

Mosquito ControlAnimalsAnophelesDose-Response Relationship, DrugGuanidinesInsecticidesKenyaLethal Dose 50MalariaMosquito VectorsNeonicotinoidsPyrethrinsSpecies SpecificityThiazoleschlorfenapyrclothianidinGuanidinesInsecticidesNeonicotinoidsPyrethrinsThiazolesAnophelesAnopheles arabiensisAnopheles funestusAnopheles gambiae sensu strictoChlorfenapyrClothianidinInsecticide resistance

Identifiers

PMID31315614
PMCPMC6637467
OpenAlexW2957430563

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.